Affiliation:
1. Hirabai Cowasji Jehangir Medical Research Institute, Pune, India
2. Adihkari Lifeline hospital, Boisar, India
3. Jehangir Hospital
Abstract
Abstract
Aims: Comparison of nerve conduction (NCS) parameters of adolescents with type-1 Diabetes (T1D) with controls. Assessment of sub-clinical peripheral neuropathy prevalence and predictors in Indian adolescents with T1D.
Methods: Case-control study. Cases(n=120):10-19 years, T1D duration>2 years. Exclusion: Comorbidities, illnesses affecting nerve function. Controls(n=40):Healthy, age, sex-matched.
Results: Mean age:15.1±3 years; diabetes duration:7±3.5 years, HbA1c:9.6±2.1% (81mmol/mol). None had symptoms/signs of peripheral neuropathy. Both groups were similar in anthropometry, physical activity. NCS comparison demonstrated significantly prolonged latency, reduced action potential duration and nerve conduction velocity (p<0.01) in motor nerves (median, ulnar, peroneal, tibial) in patients with T1D. Sensory action potential duration in median and ulnar nerves, and sural conduction velocity were significantly lesser in T1D (p<0.05).
70% had at least one abnormal NCS parameter. Sub-clinical neuropathy prevalence- demyelinating motor: upper limbs (UL)-5.8%, lower limbs (LL)-12.5%; demyelinating sensory:UL-52.5%, LL-5.0%; axonal motor:UL-19.2%, LL-10.8%; axonal sensory: UL-11.7%, LL-6.7%. Eight (6.6%) had stage-1a distal symmetrical polyneuropathy. Poor glycemic control (OR=2.0), reduced insulin sensitivity (OR=1.8), advancing age (OR=1.4), reduced iron intake (OR=0.8) were significant predictors of sub-clinical neuropathy.
Conclusion: The prevalence of sub-clinical peripheral neuropathy in Indian adolescents with T1D was high, with the highest prevalence of sub-clinical neuropathy being noted in the upper limbs. Despite no symptoms, NCS parameters were adversely affected in T1D, highlighting the need for early NCS-based screening. Poor glycemic control, reduced insulin sensitivity, advancing age, reduced iron intake were predictors of sub-clinical neuropathy.
Publisher
Research Square Platform LLC
Reference38 articles.
1. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes;Bjornstad P;Pediatr. Diabetes,2022
2. E.J. Boyko, D.J. Magliano, S. Karuranga, L. Piemonte, P. Riley, P. Saeedi et al., (2021). IDF Diabetes Atlas 10th Edition. Accessed March 31, 2022. Retrieved from: https://diabetesatlas.org/atlas/tenth-edition
3. Point Prevalence of Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetes Mellitus;Singh DP;Indian J. Pediatr.,2022
4. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2);Louraki M;Diabetes Res. Clin. Pract.,2016
5. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity;Dyck PJ;Diabetes Metab. Res. Rev.,2011